USA: Therapy with glucagon-like peptide-1 receptor agonists (GLP-1RAs) after heart transplantation was associated with ...

Since their introduction 20 years ago, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolu­tionised the treatment of diabetes and obesity. Known for their immunomodulatory and ...

By Tarun Sai Lomte An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing ...

Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

Ozempic may be more expensive and harder to find now that compounded semaglutide isn’t available. Here are seven reputable places to get a prescription online.

With the advent of oral obesity treatments as an alternative to injections, interest in obesity therapy is intensifying in ...

These drugs work by targeting GLP-1, a satiety hormone that has been sh… ...

US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...

LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration strategies for users.